Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colonic Neoplasms × oblimersen × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 2 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Stomach Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Intraocular Lymphoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Burkitt Lymphoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Leucovorin 35 Fluorouracil 33 Oxaliplatin 31 Bevacizumab 29 Irinotecan 28 Cetuximab 21 Capecitabine 16 Panitumumab 13 IFL protocol 6 Folfox protocol 6 Nivolumab 5 Immunohistochemistry 5 pembrolizumab 4 Ramucirumab 4 Radiotherapy 4 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 aflibercept 3 Surgical Procedures, Operative 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Gemcitabine 3 Fluorodeoxyglucose F18 3 Fentanyl 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Celecoxib 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡